Beta-lactam target attainment and associated outcomes in patients with bloodstream infections
Bloodstream infections (BSIs) are associated with significant morbidity and mortality. Specifically, Gram-negative BSIs might be associated with higher early mortality compared to BSIs caused by Gram-positive bacteria. These Gram-negative organisms may lead to serious therapeutic problems because of the increased incidence of multidrug resistance.